Burkitt lymphoma in children: The Israeli experience

Keyphrases

• Burkitt Lymphoma 100%
• Diffuse Large B-cell 100%
• Overall Survival 80%
• Bone Marrow 60%
• Event-free Survival 60%
• Abdomen 40%
• Central Nervous System Involvement 40%
• Tumor Lysis Syndrome 40%
• Head-and-neck 40%
• LMB-96 40%
• Israel 20%
• No Significant Difference 20%
• In(III) 20%
• Kaplan-Meier 20%
• B-cell non-Hodgkin Lymphoma (B-NHL) 20%
• Jews 20%
• Central Nervous System 20%
• Risk Factors 20%
• First Year 20%
• Lymphoma 20%
• Genetic Influences 20%
• Cellular Origin 20%
• Therapeutic Approaches 20%
• 3-group 20%
• Histology 20%
• Group 14 20%
• Multiple Organ Failure 20%
• Bone Marrow Involvement 20%
• Prognostic Factors 20%
• Site of Disease 20%
• Jewish Patients 20%
• Group Treatment 20%
• Cure Rate 20%
• Mediastinal Mass 20%
• Mediastinal Tumor 20%
• Mature B-cell Lymphoma 20%
• B-lines 20%

Medicine and Dentistry

• B Cell 100%
• Burkitt's Lymphoma 100%
• Overall Survival 66%
• Central Nervous System 50%
• Event Free Survival 50%
• Neck 33%
• Lactate Dehydrogenase 33%
• Tumor Lysis Syndrome 33%
• Mediastinum 33%
• B-Cell Lymphoma 16%
• Prognostic Factor 16%
• Non-Hodgkin Lymphoma 16%
• Isoniazid 16%
• Leukemia 16%
• Group Therapy 16%
• Multiple Organ Dysfunction Syndrome 16%
• Mediastinum Mass 16%
• Mediastinal Tumor 16%
• Adolescence 16%
• Diseases 16%
• Histology 16%
• Genetics 16%
• Median Follow Up 16%